July 25, 2016
Clinical Trial Gave Me Quality of Life: A Continued Fight for the DMD Community
Read More
May 13, 2016
RARECast: Marathon Preps DMD Drug for FDA
Read More
May 9, 2016
Marathon Pharmaceuticals Presents Analyses at AAN of a Phase III Clinical Study of Deflazacort in Patients with Duchenne Muscular Dystrophy (DMD)
Read More
April 30, 2016
Introducing the Path To Hope Campaign in Response to FDA Decision on Eteplirsen
Read More
December 31, 2015
For Father of Son with Duchenne, It Is a Hopeful Season
Read More
August 19, 2015
Manchester City Fan Gets United Tattoo to Fundraise for Son’s Treatment
Read More
August 17, 2015
FibroGen On Track for Duchenne Treatment Clinical Trial
Read More
January 9, 2013
Muscular Dystrophy Briefs: Gene Therapy, Exon Skipping, Stem Cells
Read More
X